Source: Medicines & Healthcare Products Regulatory Agency (GB) Revision Year: 2020 Publisher: Gedeon Richter Plc., Gyömrői út 19-21., 1103 Budapest, Hungary
Vagirux 10 micrograms vaginal tablets.
| Pharmaceutical Form |
|---|
|
Vaginal tablet. White, round, film coated tablets embossed with “E” on one side. |
Each vaginal tablet contains 10 micrograms estradiol (as estradiol hemihydrate).
The diameter of the tablet is approximately 6 mm.
For the full list of excipients, see section 6.1.
| Active Ingredient | Description | |
|---|---|---|
| Estradiol |
Estradiol, is chemically and biologically identical to endogenous human estradiol. It substitutes for the loss of oestrogen production in menopausal women, and alleviates menopausal symptoms. Oestrogens prevent bone loss following menopause or ovariectomy. |
| List of Excipients |
|---|
|
Tablet core: Hypromellose Film-coating: Hypromellose |
Vagirux tablets are packed in PVC/PVDC/aluminium blister packs.
The blisters are packed into cardboard boxes accompanied by a multiple-use applicator sealed separately in foil.
Pack sizes: 18 × or 24 × vaginal tablets with one applicator in each box.
Not all pack sizes may be marketed.
Gedeon Richter Plc., Gyömrői út 19-21., 1103 Budapest, Hungary
PL 04854/0184
20/08/2020
| Drug | Countries | |
|---|---|---|
| VAGIRUX | Estonia, Finland, Croatia, Ireland, Lithuania, Malta, Poland, United Kingdom |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
